| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5603918 | BOEHRINGER INGELHEIM | Aerosol composition of a salt of ipratropium and a salt of albuterol |
Jun, 2015
(8 years ago) | |
Combivent is owned by Boehringer Ingelheim.
Combivent contains Albuterol Sulfate; Ipratropium Bromide.
Combivent has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Combivent are:
- US5603918
Combivent was authorised for market use on 24 October, 1996.
Combivent is available in aerosol, metered;inhalation dosage forms.
The generics of Combivent are possible to be released after 09 June, 2015.
Drugs and Companies using ALBUTEROL SULFATE; IPRATROPIUM BROMIDE ingredient
Market Authorisation Date: 24 October, 1996
Treatment: NA
Dosage: AEROSOL, METERED;INHALATION
More Information on Dosage
COMBIVENT family patents
